Pulmonary Embolism Risks

Pulmonary embolism risks are shaped by a complex interplay of genetic, medical, and lifestyle factors that increase the likelihood of clot formation and migration to the pulmonary arteries. Venous thromboembolism, the precursor of pulmonary embolism, often begins with deep vein thrombosis in the legs. Prolonged immobility, such as during long flights, extended hospitalization, or postoperative recovery, is one of the most recognized contributors. Individuals with malignancies, particularly those undergoing chemotherapy, carry an elevated risk due to cancer-related hypercoagulability. Hormonal influences, including oral contraceptives and hormone replacement therapy, can further heighten vulnerability, especially in women with additional risk factors like smoking or obesity. Genetic predispositions, such as Factor V Leiden mutation or deficiencies of natural anticoagulants like protein C and protein S, create a lifelong risk profile, often requiring close monitoring. Chronic illnesses including heart failure, chronic kidney disease, and inflammatory disorders also contribute through systemic changes in blood flow and clotting mechanisms. Infections, particularly severe respiratory or systemic infections, have recently gained attention as transient risk factors. Importantly, age amplifies nearly all other contributors, with older adults experiencing markedly higher rates of pulmonary embolism. Recognizing pulmonary embolism risks allows clinicians to stratify patients, implement targeted prophylaxis, and prevent life-threatening events. From compression stockings and early mobilization after surgery to pharmacological prophylaxis in high-risk groups, prevention strategies are tailored to individual risk profiles. Increasing awareness among patients and providers alike remains crucial in reducing the burden of pulmonary embolism.